ALX Oncology
ALXO
#9346
Rank
โ‚ฌ0.12 B
Marketcap
0,97ย โ‚ฌ
Share price
3.92%
Change (1 day)
-22.18%
Change (1 year)

EPS for ALX Oncology (ALXO)

EPS in 2026 (TTM): -0,97ย โ‚ฌ

According to ALX Oncology's latest financial reports the company's current EPS (TTM) is -1,03ย โ‚ฌ. In 2025 the company made an earnings per share (EPS) of -1,73ย โ‚ฌ an increase over its 2024 EPS that were of -2,37ย โ‚ฌ.

EPS history for ALX Oncology from 2020 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-0,97ย โ‚ฌ-44.13%
2025-1,73ย โ‚ฌ-26.92%
2024-2,37ย โ‚ฌ
2022-2,76ย โ‚ฌ47.09%
2021-1,88ย โ‚ฌ39.49%
2020-1,35ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
ORIC Pharmaceuticals
ORIC
-1,23ย โ‚ฌ 19.47%๐Ÿ‡บ๐Ÿ‡ธ USA